Nations Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $853K | Sell |
6,753
-75
| -1% | -$9.88K | 0.04% | 418 |
|
|
2026
Q1 | $952K | Buy |
6,828
+158
| +2% | +$22.1K | 0.05% | 381 |
|
|
2025
Q4 | $819K | Buy |
6,670
+58
| +0.9% | +$7.05K | 0.04% | 405 |
|
|
2025
Q3 | $734K | Buy |
6,612
+16
| +0.2% | +$1.82K | 0.05% | 405 |
|
|
2025
Q2 | $731K | Buy |
6,596
+401
| +6% | +$42.7K | 0.05% | 368 |
|
|
2025
Q1 | $694K | Sell |
6,195
-2,135
| -26% | -$220K | 0.05% | 352 |
|
|
2024
Q4 | $769K | Sell |
8,330
-117
| -1% | -$10.5K | 0.06% | 332 |
|
|
2024
Q3 | $708K | Buy |
8,447
+2,813
| +50% | +$215K | 0.05% | 355 |
|
|
2024
Q2 | $387K | Buy |
5,634
+559
| +11% | +$37.3K | 0.03% | 479 |
|
|
2024
Q1 | $372K | Buy |
5,075
+9
| +0.2% | +$692 | 0.03% | 489 |
|
|
2023
Q4 | $410K | Sell |
5,066
-62
| -1% | -$4.83K | 0.04% | 433 |
|
|
2023
Q3 | $384K | Sell |
5,128
-1,002
| -16% | -$77.1K | 0.04% | 428 |
|
|
2023
Q2 | $472K | Buy |
6,130
+368
| +6% | +$29.4K | 0.05% | 399 |
|
|
2023
Q1 | $478K | Buy |
5,762
+261
| +5% | +$21.6K | 0.05% | 379 |
|
|
2022
Q4 | $472K | Buy |
5,501
+2,068
| +60% | +$164K | 0.05% | 373 |
|
|
2022
Q3 | $212K | Sell |
3,433
-145
| -4% | -$9.14K | 0.03% | 482 |
|
|
2022
Q2 | $221K | Sell |
3,578
-618
| -15% | -$38.3K | 0.03% | 466 |
|
|
2022
Q1 | $249K | Buy |
4,196
+1,091
| +35% | +$69.7K | 0.03% | 459 |
|
|
2021
Q4 | $225K | Sell |
3,105
-175
| -5% | -$12.1K | 0.03% | 445 |
|
|
2021
Q3 | $229K | Sell |
3,280
-605
| -16% | -$42.5K | 0.03% | 406 |
|
|
2021
Q2 | $268K | Buy |
3,885
+726
| +23% | +$48.5K | 0.04% | 349 |
|
|
2021
Q1 | $204K | Buy |
+3,159
| New | +$204K | 0.05% | 333 |
|
|
2020
Q4 | – | Sell |
-3,788
| Closed | -$239K | – | 318 |
|
|
2020
Q3 | $239K | Sell |
3,788
-298
| -7% | -$20.7K | 0.07% | 255 |
|
|
2020
Q2 | $314K | Sell |
4,086
-4,055
| -50% | -$311K | 0.11% | 207 |
|
|
2020
Q1 | $609K | Sell |
8,141
-4,361
| -35% | -$301K | 0.26% | 124 |
|
|
2019
Q4 | $812K | Buy |
12,502
+202
| +2% | +$13.2K | 0.28% | 112 |
|
|
2019
Q3 | $784K | Buy |
12,300
+7,928
| +181% | +$518K | 0.28% | 110 |
|
|
2019
Q2 | $295K | Buy |
4,372
+274
| +7% | +$18K | 0.2% | 135 |
|
|
2019
Q1 | $266K | Buy |
4,098
+273
| +7% | +$18.1K | 0.18% | 139 |
|
|
2018
Q4 | $239K | Buy |
3,825
+149
| +4% | +$10.4K | 0.19% | 131 |
|
|
2018
Q3 | $284K | Buy |
3,676
+26
| +0.7% | +$1.96K | 0.2% | 126 |
|
|
2018
Q2 | $259K | Hold |
3,650
| – | – | 0.22% | 131 |
|
|
2018
Q1 | $275K | Buy |
3,650
+700
| +24% | +$55.6K | 0.25% | 115 |
|
|
2017
Q4 | $211K | Sell |
2,950
-100
| -3% | -$7.59K | 0.19% | 139 |
|
|
2017
Q3 | $247K | Hold |
3,050
| – | – | 0.24% | 126 |
|
|
2017
Q2 | $216K | Hold |
3,050
| – | – | 0.18% | 158 |
|
|
2017
Q1 | $207K | Sell |
3,050
-155
| -5% | -$10.9K | 0.2% | 140 |
|
|
2016
Q4 | $230K | Sell |
3,205
-369
| -10% | -$27.4K | 0.25% | 126 |
|
|
2016
Q3 | $283K | Buy |
3,574
+788
| +28% | +$64K | 0.28% | 111 |
|
|
2016
Q2 | $232K | Buy |
+2,786
| New | +$247K | 0.24% | 133 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Nations Financial Group's GILD Position: Q2 2026 in Review
Nations Financial Group reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $9.88K and leaving 6,753 shares worth $853K. The position accounts for 0.04% of the portfolio, ranked #418.
Nations Financial Group first reported a position in GILD in Q2 2016 and has held it in 40 quarters since. The position peaked at $952K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nations Financial Group held 6,753 shares of Gilead Sciences worth $853K as of Q2 2026.
- Nations Financial Group sold 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
- Gilead Sciences made up 0.04% of Nations Financial Group's portfolio in Q2 2026, its #418 holding.
- Nations Financial Group first reported a position in Gilead Sciences in Q2 2016 and has held it in 40 quarters since.
- Nations Financial Group's Gilead Sciences position peaked at $952K in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.